It is tempting to speculate that increased turnover of extracellular matrix in sarcomas is at least in part mediated by BMPR1A and this contributes to the observed poor prognosis of patients with BMPR1A-biased signalling. This evidence concerns the gene BMPR1A and sarcoma.